Talampanel.
Talampanel is a novel anticonvulsant that acts as an allosteric inhibitor of the AMPA receptor. Talampanel has a broad spectrum of action in animal models of epilepsy and neuroprotection. Clinical experience to date has been able to show effectiveness in reduction of seizures in patients with refractory partial seizures.
Howes
John F
JF
Department of New Drug Development, IVAX Research, Inc., Miami, Florida 33137, USA.
Bell
Cynthia
C
D000818:Animals; D000970:Antineoplastic Agents; D001569:Benzodiazepines; D001921:Brain / Q000187:drug effects; D002986:Clinical Trials as Topic; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans
D000970:Antineoplastic Agents; D001569:Benzodiazepines; C085266:talampanel